论文部分内容阅读
作者分析了５０例睾丸精原细胞瘤的疗效及预后因素。术后单纯放疗２４例，放疗加化疗１３例，两组的５年、１０年生存率分别为９１．７％及８４．３％，Ｐ＞０．０５，单纯化疗１３例，５年生存率为９０．９％，与放疗、化疗组相比，Ｐ＞０．０５。年龄＜４０岁和≥４０岁的病例的５年、１０年生存率分别为９５．７％和６８．８％，Ｐ＜０．０５。结果表明，Ⅰ期睾丸精原细胞瘤病例手术后宜行单纯放疗，若复发，可行放疗加化疗；年龄较轻的病例生存率较高；β－绒毛膜促性腺激素水平、隐睾及隐睾部位与生存率关系不大。
The authors analyzed the efficacy and prognostic factors of 50 cases of testicular seminoma. The postoperative radiotherapy alone 24 cases, radiotherapy and chemotherapy in 13 cases, 5-year and 10-year survival rates were 91.7% and 84.3%, P> 0.05, chemotherapy alone in 13 cases, 5-year survival rate 90.9%, compared with radiotherapy and chemotherapy group, P> 0.05. The 5-year and 10-year survival rates were 95.7% and 68.8% for patients aged <40 years and ≥40 years, respectively, P <0.05. The results showed that stage Ⅰ testicular seminoma cases should be treated with radiotherapy alone after surgery, if recurrence, viable radiotherapy and chemotherapy; younger cases higher survival rate; β-chorionic gonadotropin levels, cryptorchidism and cryptorchidism There is little relationship between the site and survival rate.